ClearRing
An innovative, minimally invasive medical device used for treatment of Benign Prostatic Hyperplasia symptoms.
Total Cost €
0EC-Contrib. €
0Partnership
0Views
0ClearRing project word cloud
Explore the words cloud of the ClearRing project. It provides you a very rough idea of what is the project "ClearRing" about.
Project "ClearRing" data sheet
The following table provides information about the project.
| Coordinator |
PROARC MEDICAL LTD
Organization address contact info |
| Coordinator Country | Israel [IL] |
| Project website | http://proarcmedical.com/ |
| Total cost | 71˙429 € |
| EC max contribution | 50˙000 € (70%) |
| Programme |
1. H2020-EU.3.1.4. (Active ageing and self-management of health) 2. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT)) 3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument) 4. H2020-EU.3.1.6. (Health care provision and integrated care) |
| Code Call | H2020-SMEINST-1-2016-2017 |
| Funding Scheme | SME-1 |
| Starting year | 2018 |
| Duration (year-month-day) | from 2018-01-01 to 2018-04-30 |
Partnership
Take a look of project's partnership.
| # | ||||
|---|---|---|---|---|
| 1 | PROARC MEDICAL LTD | IL (PARDES HANA) | coordinator | 50˙000.00 |
Map
Project objective
There are approximately 30 million men worldwide who experience moderate to severe Benign Prostatic Hyperplasia (BPH) symptoms. These symptoms, such as urgent need to urinate, difficulty starting urination, weak stream, or increased frequency of urination, are severe enough to disrupt a patient’s daily lifestyle. Of the 30 million sufferers, an estimated 25% require immediate active treatment. Transurethral Resection of the Prostate (TURP), the current gold standard procedure, is costly, ineffective, and can lead to harsh side effects such as infertility, erectile dysfunction, and bladder irritability, while alpha blockers can lead to weakness, dizziness, and headaches. Therefore, there is a significant unmet need for minimally invasive BPH therapy as a less costly, tolerable, and safe alternative to drugs and surgery. Pro Arc Medical is introducing the ClearRing system, designed to expand the prostate and provide immediate relief of BPH symptoms. Because all of the tools necessary are located within the housing of the elongated shaft, the device can easily be inserted and removed without the need for extraneous procedures. The ClearRing system will bring an immediate cost reduction and time advantage to surgeons and hospitals. The minimally invasive procedure will reduce the range and severity of side effects allowing patients to resume their normal lifestyles potentially twice as fast as the current standard operation procedure. During the feasibility assessment, a go-to-market strategy and a supply chain will be established, as well as further development plan will be drafted. Pro Arc will upgrade the ClearRing system, as well as optimize the system in order to allow for two implants to be inserted at the same time during the second phase of innovation project. A clinical trial will then be initiated to obtain ISO 13845 and CE mark.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CLEARRING" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "CLEARRING" are provided by the European Opendata Portal: CORDIS opendata.